FDA Status: Not Cleared Summary: Cartilage defects are frequently present in patients with FAI. Several arthroscopic treatment options are available including MFx and AMIC. In the present study tha AMIC technique using a collagen type I/III bilayer matrix (Chondro-GideV R ) is having advantages in maintaining clinical improvements over time with less complications when compared to MFx in FAI. Purpose: The aim of this study is a single-centre retrospective analysis of the efficacy of arthroscopic autologous matrix induced chondrogenesis (AMIC) compared to microfracture (MFx) for the treatment of acetabular cartilage defects in femoro acetabular impingement (FAI) at 7 years follow-up. Materials and Methods: 50 patients (35 male, 15 female) were treated with arthroscopic MFx and 59 patients (27 male, 32 female) were treated with arthroscopic AMIC with the application of a collagen type I/III bilayer matrix (Chondro-GideV R ). Patients were evaluated pre-and postoperatively by the modified Harris Hip Score (mHHS) al 6, 12 months and then yearly until final follow-up. Data are reported as mean6standard deviation. Mean patient age at surgery was 38610 (range 19-54 years) for MFx and 3969 (range 18-50 years) for AMIC. All patients presented grade III to IV chondral defects (ICRS classification) with a mean lesion size of 3.661.4 cm 2 (range2-8 cm 2 ) for MFx and 3.561.5 cm 2 (range 2-8 cm 2 ) for AMIC. 20 patients in the MFx an 24 patients in the AMIC group had a concomitant chondropaty of the femoral head treated with microfracture only. Results: Baseline mHHS was 4865 for MFx and 4466 for AMIC. Major improvement was observed and comparable in the first 6 and up to 12 months after surgery, MFx 8669 and AMIC 8368. In the AMIC group this result was maintained over time with a mHHS of 8167 at 7 years, while outcome in the MFx group deteriorated to 75610. This deterioration was even more prominent in patients with large (¼4 cm 2 ) lesions. The mean mHHS improvement at 7 years follow-up with respect to preoperative level was 26610 for MFx ad significantly higher with 3767 for AMIC. 9 patients in the MFx group subsequently required total hip arthroplasty (THA) compared to none in the AMIC group. Conclusions: MFx and AMIC both led to clinical shortterm improvement in patients with acetabular cartilage defects in FAI. AMIC, however, gave significantly better results which were maintained at a mean of 7 years followup, particularly in patients with large (¼4 cm 2 ) lesions. The conversion rate to THA was higher in the MFx group, with 9 patients (18%) requiring THA subsequently, compared to none in the AMIC group.
